Prognostic Value of Preoperative Assessment of Left Ventricular Function in Patients Undergoing Percutaneous Coronary Intervention
- PMID: 39077497
- PMCID: PMC11264021
- DOI: 10.31083/j.rcm2403080
Prognostic Value of Preoperative Assessment of Left Ventricular Function in Patients Undergoing Percutaneous Coronary Intervention
Abstract
Background: Patients may experience a decline in cardiac function even after successful percutaneous coronary intervention (PCI). It is apparent that the assessment of left ventricular (LV) function before PCI is often overlooked. The purpose of this review is to explore the significance of LV function assessment before PCI by comparing the differences in short- and long-term PCI outcomes between patients with different LV ejection fraction (LVEF) stratified preoperatively.
Methods: PubMed and Scopus were searched to identify potential studies from January 1, 2001 through January 1, 2022.
Results: A total of 969,868 participants in 33 studies at different stratifications of baseline LVEF were included in this review and their PCI outcomes were stratified for analysis. The hazard ratio of all-cause mortality within 30 days, one year and greater than 1 year after PCI between patients with abnormal and normal LVEF were 2.96 [95% CI, 2.2, 3.98], 3.14 [95% CI, 1.64, 6.01] and 3.08 [95% CI, 2.6, 3.64]; moderately impaired LV function versus normal were 2.32 [95% CI, 1.85, 2.91], 2.04 [95% CI, 1.37, 3.03], 1.93 [95% CI, 1.54, 2.44]; poor LV function versus normal were 4.84 [95% CI, 3.83, 6.1], 4.48 [95% CI, 1.37, 14.68], 6.59 [95% CI, 4.23, 10.27].
Conclusions: A moderate or severe reduction in patients' LVEF may have a serious impact on PCI prognosis. We strongly advocate for adequate assessment of LVEF before PCI as this will assist in choosing the optimal revascularization and postoperative treatment, thereby reducing short- and long-term mortality.
Keywords: left ventricular ejection fraction; percutaneous coronary intervention; prognostic.
Copyright: © 2023 The Author(s). Published by IMR Press.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Gruntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet . 1978;1:263. - PubMed
-
- Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. The New England Journal of Medicine . 2010;362:2155–2165. - PubMed
-
- Jernberg T, Johanson P, Held C, Svennblad B, Lindbäck J, Wallentin L, et al. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. The Journal of the American Medical Association . 2011;305:1677–1684. - PubMed
-
- Piccolo R, Cassese S, Galasso G, Niglio T, De Rosa R, De Biase C, et al. Long-term clinical outcomes following sirolimus-eluting stent implantation in patients with acute myocardial infarction. A meta-analysis of randomized trials. Clinical Research in Cardiology . 2012;101:885–893. - PubMed
-
- Kalesan B, Pilgrim T, Heinimann K, Räber L, Stefanini GG, Valgimigli M, et al. Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction. European Heart Journal . 2012;33:977–987. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
